Skip to main content


Volume 8 Supplement 2

Interleukin-6, a pleiotropic cytokine


Edited by Josef Smolen

Supported by an educational grant from Roche Pharmaceuticals

  1. Content type: Review

    In the late 1960s, the essential role played by T cells in antibody production was reported. This led to our hypothesis that certain molecules would have to be released from T cells to effect the stimulation o...

    Authors: Tadamitsu Kishimoto

    Citation: Arthritis Research & Therapy 2006 8(Suppl 2):S2

    Published on:

  2. Content type: Review

    Interleukin (IL)-6 is produced at the site of inflammation and plays a key role in the acute phase response as defined by a variety of clinical and biological features such as the production of acute phase pro...

    Authors: Cem Gabay

    Citation: Arthritis Research & Therapy 2006 8(Suppl 2):S3

    Published on:

  3. Content type: Review

    IL-6 is a pleiotropic cytokine involved in both the initiation and the maintenance of the inflammatory and immunologic responses in certain autoimmune diseases. Blocking of these two complementary functions of...

    Authors: Peter E Lipsky

    Citation: Arthritis Research & Therapy 2006 8(Suppl 2):S4

    Published on:

  4. Content type: Review

    The therapeutic success of biological agents, especially the tumour necrosis factor (TNF) inhibitors, has opened a new chapter in the book of therapies for rheumatoid arthritis. Nevertheless, more than 50% of ...

    Authors: Josef S Smolen and Ravinder N Maini

    Citation: Arthritis Research & Therapy 2006 8(Suppl 2):S5

    Published on:

    The Erratum to this article has been published in Arthritis Research & Therapy 2006 8:407

Annual Journal Metrics